Sean Xiaochun Zhu

4PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyMolecular targetsBasic pharmacologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2024
Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects.

Hao Chen, Abhi Shah, Suguru Kato

|May 24, 2024
A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants.

Michael J Hanley, Steven Zhang, Robert Griffin

|Sep 29, 2023
Investigation of the absolute bioavailability, mass balance, metabolism, and excretion of the cholesterol 24-hydroxylase inhibitor soticlestat in healthy volunteers.

Wei Yin, T Eric Ballard, Sean Xiaochun Zhu

|Aug 17, 2023
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations.

Minxia Michelle He, Sean Xiaochun Zhu, Joe R Cannon

Pageof 1

Frequent Collaborators

1 joint publications

Constanze Hilgendorf

1 joint publications

Wei Yin

1 joint publications

Michael J Hanley

1 joint publications

Robert Griffin